FeatureName:primary_tumor_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:t3/t2/t1/t4|Statistics:  9.287791|Direction: 1|PValue:0.025699436|FDR:0.64547024;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  9.348488|Direction: 1|PValue:0.024999044|FDR:0.17605827;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:710.000000|Direction: 1|PValue:0.011811774|FDR:0.12629512;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.318062|Direction: 1|PValue:0.002528891|FDR:0.01025596;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.322101|Direction: 1|PValue:0.002210598|FDR:0.00917718;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.265073|Direction: 1|PValue:0.012564743|FDR:0.13522007;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.287064|Direction: 1|PValue:0.006693468|FDR:0.02269249;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.328487|Direction: 1|PValue:0.001780425|FDR:0.00859575;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.210490|Direction: 1|PValue:0.049015916|FDR:0.23493836;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.307414|Direction: 1|PValue:0.003574412|FDR:0.01910936;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.346425|Direction:-1|PValue:0.000945384|FDR:0.01314084;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.351693|Direction:-1|PValue:0.000779373|FDR:0.00492422;FeatureName:4q35.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.273133|Direction:-1|PValue:0.010031630|FDR:0.16213353;FeatureName:8p22_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.226552|Direction:-1|PValue:0.033792560|FDR:0.22367457;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.393236|Direction:-1|PValue:0.000150634|FDR:0.00105260;FeatureName:17p12_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.212514|Direction:-1|PValue:0.046831867|FDR:0.18714084;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.244840|Direction:-1|PValue:0.021500582|FDR:0.29885809;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.298097|Direction:-1|PValue:0.004789727|FDR:0.02147652;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.226868|Direction:-1|PValue:0.033538416|FDR:0.22147745